2022 Interim Award Funding Policy

The Department of Health and Human Services (HHS), including NIH, operates under the Further Extending Government Funding Act (Public Law 117-70) signed by President Biden on December 3, 2021. This Act (CR) continues government operations through February 18, 2022 at the FY 2021 enacted level, with no reduction.

NIDDK extramural research is organized into 3 programmatic divisions: 1) Diabetes, Endocrinology, and Metabolic Diseases; 2) Digestive Diseases and Nutrition; and 3) Kidney, Urologic, and Hematologic Diseases.

Until FY 2022 appropriations are enacted, NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-058.html for details.

  • NIDDK will announce additional details regarding its interim FY 2022 funding policy, including details regarding funding of competing grant applications as information becomes available.